相关实验视频

Updated: Jul 5, 2025

A Flow Cytometry-based Assay for Measuring Mitochondrial Membrane Potential in Cardiac Myocytes After Hypoxia/Reoxygenation

A Flow Cytometry-based Assay for Measuring Mitochondrial Membrane Potential in Cardiac Myocytes After Hypoxia/Reoxygenation

Published on: July 13, 2018

MCJ:在肺高血压中进行心脏干预的线粒体点

Ayelén M Santamans¹, Beatriz Cicuéndez¹, Alfonso Mora^1,2

¹Cardiovascular Risk Factors and Brain Function Program, Centro Nacional de Investigaciones Cardiovasculares (CNIC), Madrid, Spain.

Science advances

|January 19, 2024

概括

慢性缺氧时,MCJ蛋白水平增加,这是肺高血压的关键因素. 切除MCJ保护右心室免受损伤,为这种疾病提供了一个新的治疗点.

科学领域:

心血管生物学心血管生物学
肺部医学肺部医学
线粒体功能的功能

背景情况:

肺高血压 (PH) 严重影响心脏功能,往往导致右心力衰竭和死亡.
目前对PH中心脏参与的理解有限,这阻碍了有效的治疗开发.
慢性缺氧是PH和相关心脏重塑的重要贡献者.

研究的目的:

调查MCJ在慢性缺氧心脏反应中的作用.
为了确定MCJ调制是否可以防止右心室 (RV) 功能障碍和重塑.
阐明MCJ在PH中的保护作用背后的分子机制.

主要方法:

在各种慢性缺氧模型中分析MCJ表达,包括COPD患者,缺氧小鼠和RV过载的猪.
在MCJ操纵后评估RV功能和心脏重塑 (例如心脏特异性沉默).
在低氧条件下对ROS/mTOR/HIF-1α信号通路的研究,以响应缺少MCJ.

主要成果:

在与慢性缺氧和PH相关的条件下,MCJ表达升高.
缺少MCJ可以保持RV功能,并防止慢性缺氧引起的心脏和肺重塑.
特定于心脏的MCJ静音保护RV功能障碍,即使有肺部变化.
MCJ 缺陷通过 ROS/mTOR/HIF-1α 轴诱导保护性预条件作用,维持 RV 缩功能.

结论:

在调节线粒体对慢性缺氧反应方面,MCJ起着至关重要的作用.
准MCJ是一种有希望的治疗策略,可以缓解慢性缺氧诱导的肺高血压和右心衰竭.
了解MCJ的作用为开发PH治疗开辟了新的途径.

更多相关视频

In vitro Assessment of Cardiac Reprogramming by Measuring Cardiac Specific Calcium Flux with a GCaMP3 Reporter

In vitro Assessment of Cardiac Reprogramming by Measuring Cardiac Specific Calcium Flux with a GCaMP3 Reporter

Published on: February 22, 2022

Improving the Accuracy of Flow Cytometric Assessment of Mitochondrial Membrane Potential in Hematopoietic Stem and Progenitor Cells Through the Inhibition of Efflux Pumps

Improving the Accuracy of Flow Cytometric Assessment of Mitochondrial Membrane Potential in Hematopoietic Stem and Progenitor Cells Through the Inhibition of Efflux Pumps

Published on: July 30, 2019

相关概念视频

Electron Transport Chain: Complex I and II

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...

Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers

Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers

Receptor tyrosine kinase inhibitors (TKIs) and calcium channel blockers (CCBs) are two critical categories of drugs employed in the treatment of pulmonary artery hypertension (PAH). PAH is a disease that causes high blood pressure in the pulmonary arteries, resulting in chest pain, fatigue, and shortness of breath.
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...

Mitochondrial Membranes

Mitochondrial Membranes

A single mitochondrion is a bean-shaped organelle enclosed by a double-membrane system. The outer membrane of mitochondria is smooth and contains many porins - the integral membrane transporters. Porins enable free diffusion of ions and small uncharged molecules through the outer mitochondrial membrane but limit the transport of molecules larger than 5000 Daltons. Further, the outer mitochondrial membrane forms a unique structure called membrane contact sites with other subcellular organelles,...